US 8388963
Antitumor combinations containing a VEGF-inhibiting agent and 5FU or a derivative thereof
granted A61KA61K31/505A61K31/513
Quick answer
US patent 8388963 (Antitumor combinations containing a VEGF-inhibiting agent and 5FU or a derivative thereof) held by REGENERON PHARMACEUTICALS, INC. expires Mon Feb 28 2033 00:00:00 GMT+0000 (Coordinated Universal Time). Status: granted.
Key facts
- Applicant
- REGENERON PHARMACEUTICALS, INC.
- Grant date
- Tue Mar 05 2013 00:00:00 GMT+0000 (Coordinated Universal Time)
- Expiration
- Mon Feb 28 2033 00:00:00 GMT+0000 (Coordinated Universal Time)
- Claims
- 14
- CPC classes
- A61K, A61K31/505, A61K31/513, A61K31/519, A61K31/7068